Press Releases for BTRX

Enter Symbol

Community Research

Stock Sentiment

Whisper Estimates

Enter Estimates

Company Profile

Technical Charts

Analyst Ratings

Analyst Estimates

Sales Estimates

Financial Ratios

Press Releases
Agile Therapeutics Appoints Industry Expert, Al Altomari, as Chairman of Its Board of Directors
Stiefel Laboratories, Inc. Successfully Completes Tender Offer for Shares of Barrier Therapeutics, Inc.
Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to the Stiefel Laboratories, Inc. Proposal to Acquire Barrier Therapeutics, Inc.
Barrier Therapeutics Introduces Dual-Component Xolegel CorePak(TM) for Seborrheic Dermatitis
BeaconEquity.com Issues TraderNotes on Active Stocks: NLN, GRVY, MDTL, ENER, BTRX, MNKD, ALTI, BG
Barrier Therapeutics, Inc. and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
Barrier Therapeutics to Merge Into Stiefel Laboratories
Vusion Baby Bottom Line Report: Many Moms Don't Know that Their Babies' Irritated Skin Could Indicate a Severe Diaper Rash that Requires Medical Treatment
Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole, USP) Gel, 2 Percent With Head & Shoulders Shampoo as Xolegel Duo - May 27 2008 1:01AM
Barrier Therapeutics Announces First Quarter 2008 Financial Results
Barrier Therapeutics to Present At the Deutsche Bank 33rd Annual Health Care Conference
Barrier Therapeutics to Release First Quarter 2008 Financial Results on April 29, 2008
Barrier Therapeutics Announces Positive Results in Reducing Itch Symptoms With Novel Oral Antihistamine Agent Hivenyl

Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia